l carnitine deficiency test Transporter – Role of carnitine in disease

While CAR-T therapy has demonstrated remarkable efficacy in hematologic malignancies such as multiple myeloma and relapsed/refractory B-cell lymphoproliferative disorders (leukemias, lymphomas) ( Figure 1 To overcome the antigen selection hurdle, significant research focuses on identifying neoantigens and unique splice variants arising from genomic alterations and aberrant RNA splicing in tumors

These tools are essential for studying advanced tissue remodeling, collagen synthesis, and cellular rejuvenation

doi: 10.1016/j.biopha.2024.116727 77

Naranmandura et al., 2012a), thereby inducing cytotoxicity in normal cells

Mobasheri, A